Human cytomegalovirus infection dysregulates the localization and stability of NICD1 and Jag1 in neural progenitor cells

Journal of Virology

Volumn 89, Issue 13, 2015, Pages 6792-6804

  Li, Xiao Jun ^a   Liu, Xi Juan ^a   Yang, Bo ^a   Fu, Ya Ru ^a   Zhao, Fei ^a   Shen, Zhang Zhou ^a   Miao, Ling Feng ^a   Rayner, Simon ^a   Chavanas, Stéphane ^b   Zhu, Hua ^c   Britt, William J ^d   Tang, Qiyi ^e   McVoy, Michael A ^f   Luo, Min Hua ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b INSERM   (France)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^e HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH INTRACELLULAR DOMAIN 1 PROTEIN; NOTCH1 RECEPTOR; PP71 PROTEIN; PROTEASOME; UL26 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; CALCIUM BINDING PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN, PP 64-69; CYTOMEGALOVIRUS PHOSPHOPROTEIN 71KDA; JAG1 PROTEIN, HUMAN; MATRIX PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, HUMAN; PROTEIN JAGGED 1; SERRATE JAGGED PROTEIN; SIGNAL PEPTIDE; VIRAL PROTEIN;

ARTICLE; CELL FATE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION; VIRUS REPLICATION; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 5;

CALCIUM-BINDING PROTEINS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAGGED-1 PROTEIN; MEMBRANE PROTEINS; NEURAL STEM CELLS; PROTEIN STABILITY; PROTEOLYSIS; RECEPTOR, NOTCH1; SERRATE-JAGGED PROTEINS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 84930914713     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00351-15     Document Type: Article

References (72)

1. Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF. 1997. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414. http://dx.doi.org/10.1542/peds.99.3.409.
2. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. 1992. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93-99. http://dx.doi.org/10.1097/00006454-199202000-00007.
3. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. 2000. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 11:283-290.
4. Karltorp E, Hellstrom S, Lewensohn-Fuchs I, Carlsson-Hansen E, Carlsson PI, Engman ML. 2012. Congenital cytomegalovirus infection: a common cause of hearing loss of unknown aetiology. Acta Paediatr 101:e357-e362. http://dx.doi.org/10.1111/j.1651-2227.2012.02711.x.
5. McMullan BJ, Palasanthiran P, Jones CA, Hall BM, Robertson PW, Howard J, Rawlinson WD. 2011. Congenital cytomegalovirus-time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification. Med J Aust 194:625-629.
6. Pati SK, Pinninti S, Novak Z, Chowdhury N, Patro RK, Fowler K, Ross S, Boppana S, NIDCD CHIMES Study Investigators. 2013. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J 32:1050-1054. http://dx.doi.org/10.1097/INF.0b013e31829bb0b9.
7. Barkovich AJ, Lindan CE. 1994. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. Am J Neuroradiol 15:703-715.
8. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW, Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB, National Institute on Deafness and Other Communication Disorders CHIMES Study. 2011. Saliva polymerase-chainreaction assay for cytomegalovirus screening in newborns. N Engl J Med 364:2111-2118. http://dx.doi.org/10.1056/NEJMoa1006561.
9. Chang WL, Tarantal AF, Zhou SS, Borowsky AD, Barry PA. 2002. A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. J Virol 76:9493-9504. http://dx.doi.org/10.1128/JVI.76.18.9493-9504.2002.
10. Kawasaki H, Kosugi I, Arai Y, Iwashita T, Tsutsui Y. 2011. Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. PLoS One 6:e17492. http://dx.doi.org/10.1371/journal.pone.0017492.
11. Perlman JM, Argyle C. 1992. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol 31:64-68. http://dx.doi.org/10.1002/ana.410310112.
12. Cheeran MC, Hu S, Ni HT, Sheng W, Palmquist JM, Peterson PK, Lokensgard JR. 2005. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res 82:839-850. http://dx.doi.org/10.1002/jnr.20682.
13. Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O'Dowd JM, Fortunato EA. 2010. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J Virol 84:3528-3541. http://dx.doi.org/10.1128/JVI.02161-09.
14. Luo MH, Schwartz PH, Fortunato EA. 2008. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. J Virol 82:9994-10007. http://dx.doi .org/10.1128/JVI.00943-08.
15. McCarthy M, Resnick L, Taub F, Stewart RV, Dix RD. 1991. Infection of human neural cell aggregate cultures with a clinical isolate of cytomegalovirus. J Neuropathol Exp Neurol 50:441-450. http://dx.doi.org/10.1097/00005072-199107000-00005.
16. Odeberg J, Wolmer N, Falci S, Westgren M, Seiger A, Soderberg-Naucler C. 2006. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol 80:8929-8939. http://dx.doi.org/10.1128/JVI.00676-06.
17. Odeberg J, Wolmer N, Falci S, Westgren M, Sundtrom E, Seiger A, Soderberg-Naucler C. 2007. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J Neurosci Res 85:583-593. http://dx.doi.org/10.1002/jnr.21144.
18. Mutnal MB, Cheeran MC, Hu S, Lokensgard JR. 2011. Murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain. PLoS One 6:e16211. http://dx.doi.org/10.1371/journal .pone.0016211.
19. Odeberg J, Browne H, Metkar S, Froelich CJ, Branden L, Cosman D, Soderberg-Naucler C. 2003. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Virol 77:4539-4545. http://dx.doi.org/10.1128/JVI.77.8.4539-4545.2003.
20. Odeberg J, Plachter B, Branden L, Soderberg-Naucler C. 2003. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 101:4870-4877. http://dx.doi.org/10.1182/blood-2002-05-1504.
21. Pan X, Li XJ, Liu XJ, Yuan H, Li JF, Duan YL, Ye HQ, Fu YR, Qiao GH, Wu CC, Yang B, Tian XH, Hu KH, Miao LF, Chen XL, Zheng J, Rayner S, Schwartz PH, Britt WJ, Xu J, Luo MH. 2013. Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection. J Virol 87:10968-10979. http://dx.doi.org/10.1128/JVI.01120-13.
22. Zhou ZD, Kumari U, Xiao ZC, Tan EK. 2010. Notch as a molecular switch in neural stem cells. IUBMB Life 62:618-623. http://dx.doi.org/10.1002/iub.362.
23. Kopan R. 2012. Notch signaling. Cold Spring Harb Perspect Biol 4:a011213. http://dx.doi.org/10.1101/cshperspect.a011213.
24. Kopan R, Ilagan MX. 2009. The canonical Notch signaling pathway:unfolding the activation mechanism. Cell 137:216-233. http://dx.doi.org/10.1016/j.cell.2009.03.045.
25. Joutel A, Tournier-Lasserve E. 1998. Notch signalling pathway and human diseases. Semin Cell Dev Biol 9:619-625. http://dx.doi.org/10.1006/scdb.1998.0261.
26. Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabasi AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Munger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M. 2012. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487:491-495. http://dx.doi.org/10.1038/nature11288.
27. Hofelmayr H, Strobl LJ, Stein C, Laux G, Marschall G, Bornkamm GW, Zimber-Strobl U. 1999. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol 73:2770-2780.
28. Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, Boshoff C. 2009. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog 5:e1000616. http://dx.doi.org/10.1371/journal.ppat.1000616.
29. Shen ZZ, Pan X, Miao LF, Ye HQ, Chavanas S, Davrinche C, McVoy M, Luo MH. 2014. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection. PLoS One 9:e88531. http://dx.doi.org/10.1371/journal.pone.0088531.
30. Fu YR, Liu XJ, Li XJ, Shen ZZ, Yang B, Wu CC, Li JF, Miao LF, Ye HQ, Qiao GH, Rayner S, Chavanas S, Davrinche C, Britt WJ, Tang Q, McVoy M, Mocarski E, Luo MH. 2015. MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a. J Virol 89:1070-1082. http://dx.doi.org/10.1128/JVI.01740-14.
31. Tamashiro JC, Hock LJ, Spector DH. 1982. Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J Virol 42:547-557.
32. Angelova M, Zwezdaryk K, Ferris M, Shan B, Morris CA, Sullivan DE. 2012. Human cytomegalovirus infection dysregulates the canonical Wnt/beta-catenin signaling pathway. PLoS Pathog 8:e1002959. http://dx.doi .org/10.1371/journal.ppat.1002959.
33. Ramos C, Rocha S, Gaspar C, Henrique D. 2010. Two Notch ligands, Dll1 and Jag1, are differently restricted in their range of action to control neurogenesis in the mammalian spinal cord. PLoS One 5:e15515. http://dx.doi.org/10.1371/journal.pone.0015515.
34. Stump G, Durrer A, Klein AL, Lutolf S, Suter U, Taylor V. 2002. Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain. Mech Dev 114:153-159. http://dx.doi.org/10.1016/S0925-4773(02)00043-6.
35. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. 2008. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad SciUSA 105:1955-1959. http://dx.doi.org/10.1073/pnas.0709663105.
36. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730. http://dx.doi.org/10.1093/hmg/8.5.723.
37. DeMeritt IB, Podduturi JP, Tilley AM, Nogalski MT, Yurochko AD. 2006. Prolonged activation of NF-kB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 346:15-31. http://dx.doi.org/10.1016/j.virol.2005.09.065.
38. Chan G, Nogalski MT, Yurochko AD. 2009. Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc Natl Acad SciUSA 106:22369-22374. http://dx.doi .org/10.1073/pnas.0908787106.
39. Aguirre A, Rubio ME, Gallo V. 2010. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature 467:323-327. http://dx.doi.org/10.1038/nature09347.
40. Schwarzer R, Dorken B, Jundt F. 2012. Notch is an essential upstream regulator of NF-kB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Leukemia 26:806-813. http://dx.doi.org/10.1038/leu .2011.265.
41. Le Borgne R. 2006. Regulation of Notch signalling by endocytosis and endosomal sorting. Curr Opin Cell Biol 18:213-222. http://dx.doi.org/10.1016/j.ceb.2006.02.011.
42. Tran K, Mahr JA, Spector DH. 2010. Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription. J Virol 84:3079-3093. http://dx.doi.org/10.1128/JVI.02236-09.
43. Koutelou E, Sato S, Tomomori-Sato C, Florens L, Swanson SK, Washburn MP, Kokkinaki M, Conaway RC, Conaway JW, Moschonas NK. 2008. Neuralized-like 1 (Neurl1) targeted to the plasma membrane by N-myristoylation regulates the Notch ligand Jagged1. J Biol Chem 283:3846-3853. http://dx.doi.org/10.1074/jbc.M706974200.
44. Winkler LL, Hwang J, Kalejta RF. 2013. Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle. J Virol 87:4665-4671. http://dx.doi .org/10.1128/JVI.03301-12.
45. Wu G, Lyapina S, Das I, Li J, Gurney M, Pauley A, Chui I, Deshaies RJ, Kitajewski J. 2001. SEL-10 is an inhibitor of notch signaling that targets Notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21:7403-7415. http://dx.doi.org/10.1128/MCB.21.21.7403-7415.2001.
46. Fehon RG, Johansen K, Rebay I, Artavanis-Tsakonas S. 1991. Complex cellular and subcellular regulation of Notch expression during embryonic and imaginal development of Drosophila: implications for notch function. J Cell Biol 113:657-669. http://dx.doi.org/10.1083/jcb.113.3.657.
47. Redmond L, Oh SR, Hicks C, Weinmaster G, Ghosh A. 2000. Nuclear Notch1 signaling and the regulation of dendritic development. Nat Neurosci 3:30-40. http://dx.doi.org/10.1038/71104.
48. Ables JL, Breunig JJ, Eisch AJ, Rakic P. 2011. Not(ch) just development:Notch signalling in the adult brain. Nat Rev Neurosci 12:269-283. http://dx.doi.org/10.1038/nrn3024.
49. Asano T, Nagahama M, Kato K. 1990. Subcellular distribution of GTPbinding proteins, Go and Gi2, in rat cerebral cortex. J Biochem 107:694-698.
50. Das S, Vasanji A, Pellett PE. 2007. Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus. J Virol 81:11861-11869. http://dx.doi.org/10.1128/JVI.01077-07.
51. Sukhdeo K, Mani M, Hideshima T, Takada K, Pena-Cruz V, Mendez G, Ito S, Anderson KC, Carrasco DR. 2012. Catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresomeautophagosome-lysosome pathway. Leukemia 26:1116-1119. http://dx .doi.org/10.1038/leu.2011.303.
52. Trgovcich J, Cebulla C, Zimmerman P, Sedmak DD. 2006. Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression. J Virol 80:951-963. http://dx.doi.org/10.1128/JVI.80.2.951-963.2006.
53. Hwang J, Kalejta RF. 2007. Proteasome-dependent, ubiquitinindependent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334-338. http://dx.doi.org/10.1016/j.virol.2007.05.037.
54. Provenzano M, Sais G, Bracci L, Egli A, Anselmi M, Viehl CT, Schaub S, Hirsch HH, Stroncek DF, Marincola FM, Spagnoli GC. 2009. A HCMVpp65 polypeptide promotes the expansion of CD4+and CD8+T cells across a wide range of HLA specificities. J Cell Mol Med 13:2131-2147. http://dx.doi.org/10.1111/j.1582-4934.2008.00531.x.
55. Song Y, Lu B. 2012. Interaction of Notch signaling modulator Numb with alpha-Adaptin regulates endocytosis of Notch pathway components and cell fate determination of neural stem cells. J Biol Chem 287:17716-17728. http://dx.doi.org/10.1074/jbc.M112.360719.
56. Irvin DK, Nakano I, Paucar A, Kornblum HI. 2004. Patterns of Jagged1, Jagged2, Delta-like 1 and Delta-like 3 expression during late embryonic and postnatal brain development suggest multiple functional roles in progenitors and differentiated cells. J Neurosci Res 75:330-343. http://dx.doi .org/10.1002/jnr.10843.
57. Kobayashi T, Kageyama R. 2010. Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling. Genes Cells 15:689-698. http://dx.doi.org/10.1111/j.1365-2443.2010.01413.x.
58. Ahmed I, Roy B, Chandrakesan P, Venugopal A, Xia L, Jensen R, Anant S, Umar S. 2013. Evidence of functional cross talk between the Notch and NF-kB pathways in nonneoplastic hyperproliferating colonic epithelium. Am J Physiol Gastrointest Liver Physiol 304:G356-G370. http://dx.doi .org/10.1152/ajpgi.00372.2012.
59. Cobbs C, Khan S, Matlaf L, McAllister S, Zider A, Yount G, Rahlin K, Harkins L, Bezrookove V, Singer E, Soroceanu L. 2014. HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget 5:1091-1100.
60. Soroceanu L, Akhavan A, Cobbs CS. 2008. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455:391-395. http://dx.doi.org/10.1038/nature07209.
61. Le Bras S, Loyer N, Le Borgne R. 2011. The multiple facets of ubiquitination in the regulation of Notch signaling pathway. Traffic 12:149-161. http://dx.doi.org/10.1111/j.1600-0854.2010.01126.x.
62. Hicke L. 2001. Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2:195-201. http://dx.doi.org/10.1038/35056583.
63. McGill MA, McGlade CJ. 2003. Mammalian Numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 278:23196-23203. http://dx.doi.org/10.1074/jbc.M302827200.
64. Moretti J, Brou C. 2013. Ubiquitinations in the Notch signaling pathway. Int J Mol Sci 14:6359-6381. http://dx.doi.org/10.3390/ijms14036359.
65. Weinmaster G, Fischer JA. 2011. Notch ligand ubiquitylation: what is it good for? Dev Cell 21:134-144. http://dx.doi.org/10.1016/j.devcel.2011.06.006.
66. Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H, Nakafuku M. 2001. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J Biol Chem 276:45031-45040. http://dx.doi.org/10.1074/jbc.M105245200.
67. Hegde NR, Tomazin RA, Wisner TW, Dunn C, Boname JM, Lewinsohn DM, Johnson DC. 2002. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J Virol 76:10929-10941. http://dx.doi.org/10.1128/JVI.76.21.10929-10941.2002.
68. Jelcic I, Reichel J, Schlude C, Treutler E, Sinzger C, Steinle A. 2011. The polymorphic HCMV glycoprotein UL20 is targeted for lysosomal degradation by multiple cytoplasmic dileucine motifs. Traffic 12:1444-1456. http://dx.doi.org/10.1111/j.1600-0854.2011.01236.x.
69. Jones TR, Wiertz EJHJ, Sun L, Fish KN, Nelson JA, Ploegh HL. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93:11327-11333. http://dx.doi.org/10.1073/pnas.93.21.11327.
70. Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL. 2010. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 207:2033-2041. http://dx.doi.org/10.1084/jem.20091793.
71. Hwang J, Kalejta RF. 2009. Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J Virol 83:6591-6598. http://dx.doi.org/10.1128/JVI.02639-08.
72. Kalejta RF, Bechtel JT, Shenk T. 2003. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasomedependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23:1885-1895. http://dx.doi.org/10.1128/MCB.23.6.1885-1895.2003.